Findings of Research Misconduct, 67305-67306 [2018-28139]

Download as PDF amozie on DSK3GDR082PROD with NOTICES1 Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices Court of Federal Claims No: 18–1424V 57. Deborah Ryan, San Pedro, California, Court of Federal Claims No: 18–1427V 58. Matthew Morales, Newark, New Jersey, Court of Federal Claims No: 18–1428V 59. Angela Malar, Cape May, New Jersey, Court of Federal Claims No: 18–1429V 60. Tatiana Dautkhanova and Ruslan Dautkhanova on behalf of E.D., Louisville, Colorado, Court of Federal Claims No: 18–1430V 61. Charlotte Dunn, Clovis, California, Court of Federal Claims No: 18–1431V 62. Brian Walker, Farmington Hills, Michigan, Court of Federal Claims No: 18–1433V 63. Thomas Creely, Pittsburgh, Pennsylvania, Court of Federal Claims No: 18–1434V 64. Staci Broadway, Rome, Georgia, Court of Federal Claims No: 18–1435V 65. Mary Ann Deubel, Millburn, New Jersey, Court of Federal Claims No: 18–1436V 66. Lissette Limonta, Palm Springs, Florida, Court of Federal Claims No: 18–1437V 67. Alyce Romines, Arab, Alabama, Court of Federal Claims No: 18–1440V 68. Maddison Rowlett, Portland, Oregon, Court of Federal Claims No: 18–1441V 69. Jay Zimmer, Dublin, California, Court of Federal Claims No: 18–1442V 70. Chey Lewis, Kernersville, North Carolina, Court of Federal Claims No: 18–1443V 71. Mary Priscilla Egan, Washington, District of Columbia, Court of Federal Claims No: 18–1444V 72. Tammy S. Gold, Dover, Ohio, Court of Federal Claims No: 18–1445V 73. Kesha Joseph on behalf of M. J. H., Deceased, Greenville, North Carolina, Court of Federal Claims No: 18–1447V 74. Rosie Estrada, Palm Springs, California, Court of Federal Claims No: 18–1448V 75. Maritza Serrano, Vega Alta, Puerto Rico, Court of Federal Claims No: 18–1449V 76. Vahan Eloyan, Thousand Oaks, California, Court of Federal Claims No: 18–1450V 77. Donna Bauer on behalf of William Bauer, Deceased, Burlington, Kansas, Court of Federal Claims No: 18–1451V 78. Vickie Ray, Fayetteville, Georgia, Court of Federal Claims No: 18–1452V 79. Donnette Giza, Washington, District of Columbia, Court of Federal Claims No: 18–1453V 80. Lisa Schwartz, Boston, Massachusetts, Court of Federal Claims No: 18–1454V 81. Gailmarie Hanna, Washington, District of Columbia, Court of Federal Claims No: 18–1455V 82. Calandra Harps, Washington, District of Columbia, Court of Federal Claims No: 18–1456V 83. Dale Jacoby, Washington, District of Columbia, Court of Federal Claims No: 18–1457V 84. Mary Jensen, Washington, District of Columbia, Court of Federal Claims No: 18–1458V 85. Jenelyn Sagala and Michael Sagala on behalf of J.S., Cambridge, Massachusetts, Court of Federal Claims No: 18–1459V 86. Jeffrey Smith, Vienna, Virginia, Court of Federal Claims No: 18–1460V 87. Catherine M. Freund, Fayetteville, New York, Court of Federal Claims No: 18– VerDate Sep<11>2014 18:13 Dec 27, 2018 Jkt 247001 1461V 88. Pearl Webbe, Boston, Massachusetts, Court of Federal Claims No: 18–1462V 89. Lisa Neuss-Guillen, Phoenix, Arizona, Court of Federal Claims No: 18–1463V 90. Heidi Levisee, Minneapolis, Minnesota, Court of Federal Claims No: 18–1464V 91. Anntoinette Reynolds on behalf of Michael Reynolds, Deceased, Mountain Home, Idaho, Court of Federal Claims No: 18–1465V 92. Tammy Copping, St. Louis, Missouri, Court of Federal Claims No: 18–1466V 93. Tim L. Lisk, Albemarle, North Carolina, Court of Federal Claims No: 18–1467V 94. Cheryl Powers, Indianapolis, Indiana, Court of Federal Claims No: 18–1468V 95. Megan Lucas, Marysville, Washington, Court of Federal Claims No: 18–1470V 96. Alexandra Soto, Lakewood, New Jersey, Court of Federal Claims No: 18–1471V 97. Jeremy Price and Gina Price on behalf of J.P., Linwood, New Jersey, Court of Federal Claims No: 18–1472V 98. Kayleen Crump Weed, Bountiful, Utah, Court of Federal Claims No: 18–1473V 99. Judith Day, Layton, Utah, Court of Federal Claims No: 18–1475V 100. Karen Goldie, Franklin, Ohio, Court of Federal Claims No: 18–1476V 101. Paul Christensen, Bellevue, Washington, Court of Federal Claims No: 18–1477V 102. Mark Crosby, Evendale, Ohio, Court of Federal Claims No: 18–1478V 103. Melissa Zielinski, Schaumburg, Illinois, Court of Federal Claims No: 18–1479V 104. Tajuana Perkins, Davenport, Florida, Court of Federal Claims No: 18–1480V 105. Mary Riviere, Jacksonville, Florida, Court of Federal Claims No: 18–1482V 106. Hope Johnson, Boston, Massachusetts, Court of Federal Claims No: 18–1486V 107. Keith A. Miller, Memphis, Tennessee, Court of Federal Claims No: 18–1487V 108. Ryan Spangler and Courtney Spangler on behalf of J.S., Chico, California, Court of Federal Claims No: 18–1488V 109. Constance Connor, Durham, North Carolina, Court of Federal Claims No: 18–1489V 110. Barbara Bowie, Upper Marlboro, Maryland, Court of Federal Claims No: 18–1490V 111. Gayzelle Thomas, Midlothian, Virginia, Court of Federal Claims No: 18–1491V 112. Matthew A. O’Brien, Maui, Hawaii, Court of Federal Claims No: 18–1492V 113. Melissa Hardin, Spartanburg, North Carolina, Court of Federal Claims No: 18–1493V 114. Rae Jean Leonard, Des Moines, Idaho, Court of Federal Claims No: 18–1495V 115. Teresa Landrum, Ocean City, New Jersey, Court of Federal Claims No: 18– 1497V 116. Sheri L. Berrier, West Des Moines, Idaho, Court of Federal Claims No: 18– 1498V 117. Carrie A. Newcomer, Bloomington, Indiana, Court of Federal Claims No: 18– 1501V 118. Elizabeth Conner Wood, Columbia, South Carolina, Court of Federal Claims No: 18–1503V 119. Pattie Patriquin, Washington, District of Columbia, Court of Federal Claims No: PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 67305 18–1504V 120. Jennifer Kappre, Washington, District of Columbia, Court of Federal Claims No: 18–1505V 121. Kelly Caven, Oklahoma City, Oklahoma, Court of Federal Claims No: 18–1506V 122. Maura McAuliffe, Washington, District of Columbia, Court of Federal Claims No: 18–1507V 123. Mary Rendon, Lewisville, Texas, Court of Federal Claims No: 18–1508V 124. Flordelisa Pascual, Vallejo, California, Court of Federal Claims No: 18–1509V 125. Anita Plouffe, Seattle, Washington, Court of Federal Claims No: 18–1510V 126. Michelle Roy, Hillsborough, New Hampshire, Court of Federal Claims No: 18–1511V 127. Terry Pitts, Washington, District of Columbia, Court of Federal Claims No: 18–1512V 128. Julia Randazzo, Washington, District of Columbia, Court of Federal Claims No: 18–1513V 129. Cheree Dowdell, Wellesley Hills, Massachusetts, Court of Federal Claims No: 18–1514V [FR Doc. 2018–28136 Filed 12–27–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: Findings of research misconduct have been made on the part of Venkata Sudheer Kumar Ramadugu, Ph.D. (Respondent), former postdoctoral scientist in the Department of Chemistry, University of Michigan (UM). Dr. Ramadugu engaged in research misconduct in research supported by National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), grant R01 GM084018 and National Institute on Aging (NIA), NIH, grant R01 AG048934. The administrative actions, including debarment for a period of five (5) years, were implemented beginning on December 4, 2018, and are detailed below. FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, Dr. P.H., Interim Director, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8200. SUPPLEMENTARY INFORMATION: Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Venkata Sudheer Kumar Ramadugu, Ph.D., University of Michigan: Based on the report of an assessment conducted by UM, the Respondent’s admission, SUMMARY: E:\FR\FM\28DEN1.SGM 28DEN1 67306 Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices and analysis conducted by ORI in its oversight review, ORI found that Dr. Venkata Sudheer Kumar Ramadugu, former postdoctoral scientist in the Department of Chemistry, UM, engaged in research misconduct in research supported by NIGMS, NIH, grant R01 GM084018 and NIA, NIH, grant R01 AG048934. ORI found that Respondent engaged in research misconduct by knowingly and intentionally falsifying and/or fabricating data reported in the following published papers and poster presentation: • Chemical Communications 53(78):10824–10826, 2017 (hereafter referred to as ‘‘Chem. Comm. 2017’’). • Angewandte Chemie-International Edition 56(38):11466–11470, 2017 (hereafter referred to as ‘‘Angewandte Chemie-International Edition 2017’’). • Angewandte Chemie-International Edition 57(5):1342–1345, 2018 (hereafter referred to as ‘‘Angewandte Chemie-International Edition 2018’’). • Polymer macrodiscs for solid-state NMR structural studies on aligned lipid bilayers.’’ Presented at the 58th Experimental Nuclear Magnetic Resonance Conference in Pacific Grove (Asilomar), California, March 25–30, 2017 (hereafter referred to as the ‘‘ENMRC Poster 2017’’). ORI found that Respondent intentionally and knowingly falsified and/or fabricated NMR spectroscopy data for structure and dynamics of nanodiscs in thirteen (13) figure panels included in three (3) published papers and one (1) poster presentation by manipulating previously generated NMR data from unrelated experiments to falsely represent NMR spectra for completely different experiments. Specifically, Respondent falsified and/ or fabricated NMR spectra in: • Chem. Comm. 2017. — Figure 2A. — Figure 2B, top and bottom panels. — Figure 3, bottom two panels of the right most column. — Figure S4, second, third, and the bottom panels from the top. • Angewandte Chemie-International Edition 2017. — Figures 4E and 4F. • Angewandte Chemie-International Edition 2018. — Figure 4B. • ENMRC Poster 2017. — Figure labelled ‘‘Magnetic Alignment of Macrodiscs,’’ bottom two panels of the right most column. Dr. Ramadugu entered into a Voluntary Exclusion Agreement (Agreement) and voluntarily agreed for a period of five (5) years, beginning on December 4, 2018: (1) Because he also made a false statement in his first admission that no other data were affected in his papers, to exclude himself from any contracting or subcontracting with any agency of the United States Government and from eligibility for or involvement in nonprocurement programs of the United States Government referred to as ‘‘covered transactions’’ pursuant to HHS’ Implementation (2 CFR part 376) of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension, 2 CFR part 180 (collectively the ‘‘Debarment Regulations’’); and (2) to exclude himself from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. Comments on the ICR must be received on or before January 28, 2019. ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Sherrette Funn, Sherrette.Funn@hhs.gov or (202) 795–7714. When submitting comments or requesting information, please include the document identifier 0990–0460–30D and project title for reference. DATES: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: Office of Adolescent Health Pregnancy Assistance Fund (PAF) Performance Measures Data Collection, FY2018– FY2020. Type of Collection: Revision. OMB No.: 0990–0460. Abstract: The Office of Adolescent Health seeks a revision of the Pregnancy Assistance Fund (PAF) performance measures data collection. A new cohort of 23 PAF grantees was funded in 2018. PAF provides funding to States and Tribes to provide expectant and parenting teens, women, fathers and their families with a seamless network of supportive services to help them complete high school or postsecondary degrees; and to help states improve services to expectant females who experience intimate partner violence or stalking, Additional measures have been proposed for addition to the existing menu of approved measures. A 3 year clearance period is requested. The respondents would be the 23 state and tribal entities receiving PAF awards in 2018. Data would be collected annually. SUPPLEMENTARY INFORMATION: Wanda K. Jones, Interim Director, Office of Research Integrity. [FR Doc. 2018–28139 Filed 12–27–18; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier: OS–0990–0460] Agency Information Collection Request; 30-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. SUMMARY: amozie on DSK3GDR082PROD with NOTICES1 ESTIMATED ANNUALIZED BURDEN TABLE Number of respondents Type of respondent All All All All All PAF PAF PAF PAF PAF Grant Grant Grant Grant Grant VerDate Sep<11>2014 Recipients Recipients Recipients Recipients Recipients (Training Form) ....................................................... (Partners Sustainability Form) ................................ (Reach Demographics Form) ................................. (Core Services) ...................................................... ( ) ............................................................................ 18:13 Dec 27, 2018 Jkt 247001 PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 Number responses per respondent 23 23 23 23 23 E:\FR\FM\28DEN1.SGM 1 1 1 1 1 28DEN1 Average burden per response (in hours) 15/60 210/60 637/60 9 5 Total burden hours 6 81 244 207 115

Agencies

[Federal Register Volume 83, Number 248 (Friday, December 28, 2018)]
[Notices]
[Pages 67305-67306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28139]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Findings of research misconduct have been made on the part of 
Venkata Sudheer Kumar Ramadugu, Ph.D. (Respondent), former postdoctoral 
scientist in the Department of Chemistry, University of Michigan (UM). 
Dr. Ramadugu engaged in research misconduct in research supported by 
National Institute of General Medical Sciences (NIGMS), National 
Institutes of Health (NIH), grant R01 GM084018 and National Institute 
on Aging (NIA), NIH, grant R01 AG048934. The administrative actions, 
including debarment for a period of five (5) years, were implemented 
beginning on December 4, 2018, and are detailed below.

FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, Dr. P.H., Interim 
Director, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8200.

SUPPLEMENTARY INFORMATION: Notice is hereby given that the Office of 
Research Integrity (ORI) has taken final action in the following case:
    Venkata Sudheer Kumar Ramadugu, Ph.D., University of Michigan: 
Based on the report of an assessment conducted by UM, the Respondent's 
admission,

[[Page 67306]]

and analysis conducted by ORI in its oversight review, ORI found that 
Dr. Venkata Sudheer Kumar Ramadugu, former postdoctoral scientist in 
the Department of Chemistry, UM, engaged in research misconduct in 
research supported by NIGMS, NIH, grant R01 GM084018 and NIA, NIH, 
grant R01 AG048934.
    ORI found that Respondent engaged in research misconduct by 
knowingly and intentionally falsifying and/or fabricating data reported 
in the following published papers and poster presentation:
     Chemical Communications 53(78):10824-10826, 2017 
(hereafter referred to as ``Chem. Comm. 2017'').
     Angewandte Chemie-International Edition 56(38):11466-
11470, 2017 (hereafter referred to as ``Angewandte Chemie-International 
Edition 2017'').
     Angewandte Chemie-International Edition 57(5):1342-1345, 
2018 (hereafter referred to as ``Angewandte Chemie-International 
Edition 2018'').
     Polymer macrodiscs for solid-state NMR structural studies 
on aligned lipid bilayers.'' Presented at the 58th Experimental Nuclear 
Magnetic Resonance Conference in Pacific Grove (Asilomar), California, 
March 25-30, 2017 (hereafter referred to as the ``ENMRC Poster 2017'').
    ORI found that Respondent intentionally and knowingly falsified 
and/or fabricated NMR spectroscopy data for structure and dynamics of 
nanodiscs in thirteen (13) figure panels included in three (3) 
published papers and one (1) poster presentation by manipulating 
previously generated NMR data from unrelated experiments to falsely 
represent NMR spectra for completely different experiments. 
Specifically, Respondent falsified and/or fabricated NMR spectra in:
     Chem. Comm. 2017.
    -- Figure 2A.
    -- Figure 2B, top and bottom panels.
    -- Figure 3, bottom two panels of the right most column.
    -- Figure S4, second, third, and the bottom panels from the top.
     Angewandte Chemie-International Edition 2017.
    -- Figures 4E and 4F.
     Angewandte Chemie-International Edition 2018.
    -- Figure 4B.
     ENMRC Poster 2017.
    -- Figure labelled ``Magnetic Alignment of Macrodiscs,'' bottom two 
panels of the right most column.
    Dr. Ramadugu entered into a Voluntary Exclusion Agreement 
(Agreement) and voluntarily agreed for a period of five (5) years, 
beginning on December 4, 2018:
    (1) Because he also made a false statement in his first admission 
that no other data were affected in his papers, to exclude himself from 
any contracting or subcontracting with any agency of the United States 
Government and from eligibility for or involvement in nonprocurement 
programs of the United States Government referred to as ``covered 
transactions'' pursuant to HHS' Implementation (2 CFR part 376) of OMB 
Guidelines to Agencies on Governmentwide Debarment and Suspension, 2 
CFR part 180 (collectively the ``Debarment Regulations''); and
    (2) to exclude himself from serving in any advisory capacity to PHS 
including, but not limited to, service on any PHS advisory committee, 
board, and/or peer review committee, or as a consultant.

Wanda K. Jones,
Interim Director, Office of Research Integrity.
[FR Doc. 2018-28139 Filed 12-27-18; 8:45 am]
 BILLING CODE 4150-31-P